🔎 Trials Near Me

Akèy › Kansè fwa (Kasinòm epatoselilè) › Arizona › Phoenix

Etid klinik pou Kansè fwa (Kasinòm epatoselilè) nan Phoenix, AZ

7 etid pou Kansè fwa (Kasinòm epatoselilè) ap chèche patisipan nan sit nan ak bò kote Phoenix (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 1 Study of the Safety and Tolerability of CTX-10726

Ap rekriteFaz 1
  • Mayo Clinic Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07419841

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Ap rekriteFaz 1
  • Exelixis Clinical Site #67, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

Ap rekriteFaz 1/2
  • Research Facility, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06726161

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Ap rekriteFaz 3
  • Research Site, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06921785

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Mayo Clinic, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Ap rekriteFaz 1
  • Clinical Trial Site, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT06600321

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Ap rekriteEtid obsèvasyon
  • Mayo Clinic in Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Mar 12, 2026 · NCT06349642

Etid Kansè fwa (Kasinòm epatoselilè) nan lòt vil

Lòt etid nan Phoenix

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.